Talk:Sarepta Therapeutics

Moved from main article
Not sure if the following belongs in the article. I looked at a few other pharmaceutical company articles and they did not have this sort of info. I'm not an expert on corporate articles so please let me know if I'm wrong. If replaced, the info really needs to be cleaned up and formatted. Katr67 23:19, 21 August 2006 (UTC) Modified by Katr67 19:09, 8 December 2006 (UTC)

Key Statistics
Market Cap (intraday):	97.65M,Enterprise Value (29-Sep-05)3:	66.79M, Trailing P/E (ttm, intraday):	N/A, Forward P/E (fye 31-Dec-06) 1:	N/A, PEG Ratio (5 yr expected):	N/A, Price/Sales (ttm):	261.09, Price/Book (mrq):	2.56, Enterprise Value/Revenue (ttm)3:	176.10, Enterprise Value/EBITDA (ttm)3:	-3.556

Financial highlights
Fiscal Year Fiscal Year Ends:	31-Dec Most Recent Quarter (mrq):	30-Jun-05 Profitability Profit Margin (ttm):	-5413.09% Operating Margin (ttm):	-5472.21% Management Effectiveness Return on Assets (ttm):	-32.97% Return on Equity (ttm):	-55.04% Income Statement Revenue (ttm):	379.25K Revenue Per Share (ttm):	0.01 Qtrly Revenue Growth (yoy):	8.40% Gross Profit (ttm):	969.87K EBITDA (ttm):	-18.78M Net Income Avl to Common (ttm):	-20.53M Diluted EPS (ttm):	-0.52 Qtrly Earnings Growth (yoy):	-31.00%

Balance Sheet
Total Cash (mrq):	32.19M Total Cash Per Share (mrq):	0.728 Total Debt (mrq):	0 Total Debt/Equity (mrq):	0 Current Ratio (mrq):	16.833 Book Value Per Share (mrq):	0.874 Cash Flow Statement From Operations (ttm):	-18.15M Free Cashflow (ttm):	-12.69M

Key Executives & Pay Exercised
Chairman, Chief Exec. Officer and Member of Exec. Committee	 $ 450.00K	 $ 0 Pres, Chief Operating Officer, Director and Member of Exec. Committee	 $ 385.00K	 $ 0 Chief Financial Officer, Principal Accounting Officer, Chief Information Officer and Controller	 $ 250.00K	 $ 0 Sr. VP of R&D	 $ 300.00K	 $ 0 Sr. VP of Chemistry and Manufacturing, Director and Member of Exec. Committee	 $ 250.00K	 $ 0
 * Dr. Denis R. Burger Ph.D., 61
 * Mr. Alan P. Timmins, 45
 * Mr. Mark M. Webber, 50
 * Dr. Patrick L. Iversen Ph.D., 49
 * Dr. Dwight D. Weller Ph.D., 54

Update
The notes above are very out-of-date, it would be reasonable to remove them from this page.

I just changed the statement that Summerton "discovered" Morpholinos so that it now states he conceived of them and then, with Weller, invented them. Also, Morpholinos were described as synthetic RNA, but their structure is quite different so I changed the description to synthetic analog of RNA.

JonMoulton (talk) 22:05, 9 July 2009 (UTC)